Skip to main content

. 1983 Dec;16(6):581–585. doi: 10.1111/j.1365-2125.1983.tb02225.x

Problems of post-marketing surveillance.

W M Castle, J T Nicholls, C C Downie

PMCID: PMC1428367 PMID: 6661341

581

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Inman W. H. Postmarketing surveillance of adverse drug reactions in general practice. II: Prescription-event monitoring at the University of Southampton. Br Med J (Clin Res Ed) 1981 Apr 11;282(6271):1216–1217. doi: 10.1136/bmj.282.6271.1216. [DOI] [PMC free article] [PubMed] [Google Scholar]
Skegg D. C., Doll R. The case for recording events in clinical trials. Br Med J. 1977 Dec 10;2(6101):1523–1524. doi: 10.1136/bmj.2.6101.1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
Strom B. L., Melmon K. L. Can postmarketing surveillance help to effect optimal drug therapy? JAMA. 1979 Nov 30;242(22):2420–2422. [PubMed] [Google Scholar]

ACTIONS

RESOURCES